Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2 is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Pew Charitable Trusts
Grant: n/a
NCI NIH HHS
Grant: R37 CA273819
NIAID NIH HHS
Grant: R01 AI051321
NCI NIH HHS
Grant: P30 CA014051
National Institutes of Health
Grant: 5P30CA014051-17
CELL BIOLOGY--DEVELOPMENTAL PROGRAM
FWCI
2.50
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals